Gross Profit for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's current gross profit (TTM) is $32.60B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$32.60B
YoY change
+18.8%
5Y CAGR
+8.5%
Peak year (2025)
$32.60B
Cumulative gross profit
$561.57B
Gross Profit history chart for Bristol-Myers Squibb (BMY) from 1987 to 2025
Gross Profit history table for Bristol-Myers Squibb (BMY) from 1987 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $32.60B | +18.8% | ||
| 2024 | $27.43B | +8.2% | ||
| 2023 | $25.36B | -4.3% | ||
| 2022 | $26.49B | -1.0% | ||
| 2021 | $26.76B | +23.3% | ||
| 2020 | $21.70B | +25.8% | ||
| 2019 | $17.25B | +7.3% | ||
| 2018 | $16.07B | +7.5% | ||
| 2017 | $14.96B | +3.2% | ||
| 2016 | $14.49B | +13.2% | ||
| 2015 | $12.81B | +6.7% | ||
| 2014 | $12.00B | +1.7% | ||
| 2013 | $11.80B | -10.5% | ||
| 2012 | $13.19B | -16.1% | ||
| 2011 | $15.72B | +9.7% | ||
| 2010 | $14.33B | +4.0% | ||
| 2009 | $13.78B | -4.6% | ||
| 2008 | $14.44B | +9.3% | ||
| 2007 | $13.21B | +13.0% | ||
| 2006 | $11.68B | -12.7% | ||
| 2005 | $13.38B | -1.4% | ||
| 2004 | $13.57B | +2.0% | ||
| 2003 | $13.30B | +13.4% | ||
| 2002 | $11.73B | -15.3% | ||
| 2001 | $13.85B | -2.5% | ||
| 2000 | $14.20B | -7.5% | ||
| 1999 | $15.36B | +9.3% | ||
| 1998 | $14.05B | +9.5% | ||
| 1997 | $12.83B | +10.4% | ||
| 1996 | $11.62B | +9.8% | ||
| 1995 | $10.58B | +15.1% | ||
| 1994 | $9.19B | +5.7% | ||
| 1993 | $8.69B | +1.1% | ||
| 1992 | $8.59B | +1.4% | ||
| 1991 | $8.47B | +10.5% | ||
| 1990 | $7.67B | +14.0% | ||
| 1989 | $6.73B | +7.5% | ||
| 1988 | $6.26B | +15.5% | ||
| 1987 | $5.42B | — |
Gross Profit values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Bristol-Myers Squibb (BMY) most recent annual gross profit stands at $32.60B (2025) – grew 18.8% year-over-year.
Bristol-Myers Squibb gross profit has grown for 2 consecutive years, with a +8.5% compound annual growth rate over 2020–2025 (5 years).
Across the available history, gross profit reached its high of $32.60B in 2025 and its low of $5.42B in 1987.
Among 8 Healthcare peers, Bristol-Myers Squibb (BMY) ranks 8th; the peer median for gross profit is $53.80B.
Bristol-Myers Squibb Gross Profit by Year
Bristol-Myers Squibb Gross Profit 2025: $32.60B
Bristol-Myers Squibb gross profit in 2025 was $32.60B, grew 18.8% from 2024. This figure represents the highest annual value in the available history.
Bristol-Myers Squibb Gross Profit 2024: $27.43B
Bristol-Myers Squibb gross profit in 2024 was $27.43B, grew 8.2% from 2023.
Bristol-Myers Squibb Gross Profit 2023: $25.36B
Bristol-Myers Squibb gross profit in 2023 was $25.36B, edged down 4.3% below 2022.
Bristol-Myers Squibb Gross Profit 2022: $26.49B
Bristol-Myers Squibb gross profit in 2022 was $26.49B, edged down 1.0% below 2021.
Bristol-Myers Squibb Gross Profit 2021: $26.76B
Bristol-Myers Squibb gross profit in 2021 was $26.76B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Gross Profit
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's gross profit?
- Latest reported gross profit for Bristol-Myers Squibb (BMY) is $32.60B (period ending December 31, 2025).
How has Bristol-Myers Squibb gross profit changed year-over-year?
- Bristol-Myers Squibb (BMY) gross profit changed +18.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb gross profit?
- Bristol-Myers Squibb (BMY) gross profit compound annual growth rate is +8.5% over the most recent 5 years available.
When did Bristol-Myers Squibb gross profit hit its highest annual value?
- Bristol-Myers Squibb gross profit reached its highest annual value of $32.60B in 2025.
What was Bristol-Myers Squibb gross profit in 2024?
- Bristol-Myers Squibb (BMY) gross profit in 2024 was $27.43B.
What was Bristol-Myers Squibb gross profit in 2025?
- Bristol-Myers Squibb (BMY) gross profit in 2025 was $32.60B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.